Nike (NKE) deep dive, April 5, 2026: 15.5% single-day plunge as China guidance triggers mass downgrades

NEW YORK, April 5, 2026. Nike (NYSE: NKE) has had one of the most violent post-earnings weeks in the company’s 46-year history as a public company. On April 1 — the first session after reporting Q3 FY2026 results the prior evening — NKE closed at $44.62, down 15.52%, on volume of 109.4 million shares — approximately 516% above its three-month daily average of 17.7 million. The following day, April 2, the stock extended its losses to print a new 52-week low of $43.17. As of Friday’s close, NKE is down approximately 28.5% year-to-date and nearly 30% since the start of 2026, within a broader five-year decline of approximately 60% from peak. Three of Wall Street’s most influential banks — Goldman Sachs, JPMorgan, and Bank of America — simultaneously downgraded the stock to Neutral, cutting price targets to $52, $52, and $55 respectively. At least ten additional firms slashed their price targets in the same session. The precipitating event: Q4 FY2026 guidance for sales to fall 2–4% versus the Street’s prior expectation of a 1.9% increase, and a disclosure that China revenue is expected to decline approximately 20% in the current quarter — a magnitude that caught even the bears by surprise.

The Q3 results — a beat that didn’t matter

Nike’s Q3 FY2026 results, reported March 31, were technically ahead of consensus. EPS of $0.35 beat the $0.29 estimate. Revenue of $11.28 billion came in slightly ahead of the $11.23 billion consensus. North America wholesale revenue grew 3%, and China’s 10% decline was better than the 16% drop analysts had modelled. Nike Running grew more than 20%. The MemoryAI — Nike Mind — footwear concept sold out. On any other earnings cycle, that combination of beats would have supported at least a neutral stock reaction. What made Wednesday’s session different is that the market had already incorporated maximum pessimism into the consensus estimates, and the guidance disclosed on the call went materially beyond even that pessimistic baseline.

The specific numbers that shattered confidence: Q4 FY2026 revenue guidance of $10.656–$10.878 billion, against the Street’s $11.236 billion estimate — a gap of approximately $400 million at the midpoint. Full-year calendar year sales guided to fall by a low single-digit percentage. Gross margin at 40.2%, down 130 basis points year-over-year due to North America tariff costs. Converse revenue collapsed 35% to $264 million. Nike Direct revenue fell 7% and Nike Digital declined 9%. And most damaging of all: CFO Matt Friend guided approximately 20% China revenue decline in Q4 — nearly double the pace of the Q3 decline. As CNBC reported, management guided sales to remain negative into Q3 FY2027, meaning the revenue trough is now approximately nine months away, not one or two. JPMorgan’s model for Nike reaching a 10% operating margin has been pushed out to fiscal 2029 — from fiscal 2028 — a one-year extension of the recovery timeline in a single quarter.

The mass downgrade — what Goldman, JPMorgan, and Bank of America each said

Goldman Sachs downgraded NKE to Neutral from Buy, cutting its price target from $76 to $52. Analyst Brooke Roach said the firm remains constructive on Nike’s “Win Now” actions and believes the Sport Offense strategy will drive sequential improvement over time — but flagged that “sportswear momentum remains muted, franchise management and inventory reset actions remain ongoing, and Europe, Middle East, Africa and China remain under particular pressure.” Goldman described itself as “incrementally cautious” about the timeline of recovery. The $52 target implies essentially no upside from Friday’s close near $44, reflecting a near-zero probability that Goldman is assigning to material positive catalysts in the near term.

JPMorgan downgraded to Neutral from Overweight, slashing its price target from $86 to $52 — a $34 reduction in a single action, one of the largest single-session price target cuts the firm has made on a mega-cap consumer name in recent memory. JPMorgan flagged “time-consuming turnaround efforts” and trimmed fiscal 2027 and 2028 earnings estimates below the sell-side consensus. The explicit pushback to fiscal 2029 for the 10% operating margin target represents a fundamental reassessment of how long Nike’s recovery will take. A $52 target from a prior $86 — a 39% reduction — captures the magnitude of JPMorgan’s confidence loss in the turnaround timeline.

Bank of America downgraded to Neutral from Buy with a $55 target, via analyst Lorraine Hutchinson. Her note to clients captured the institutional frustration most precisely: “We thought improved performance product innovation and lapping Win Now actions would result in a return to growth in Q1 FY2027; instead, management has initiated guidance for sales to remain negative into Q3 FY2027.” She added: “Strong results in running and North America were the reasons for our patience — but with the sales inflection now nine months away, we see little room for multiple expansion, leading to our downgrade.” The BofA note effectively describes Wall Street’s collective position: the bulls have been waiting for the turnaround to arrive in one quarter after another, and management has now explicitly pushed the date out by three additional quarters.

The full analyst action scorecard — ten firms cut on the same day

Beyond the three simultaneous downgrades, Wednesday produced one of the broadest single-session price target revision cascades in NKE’s recent history. The complete action log across the session:

Downgrades: Goldman Sachs (Buy→Neutral, $76→$52), JPMorgan (Overweight→Neutral, $86→$52), Bank of America (Buy→Neutral, PT $55).

Price target cuts with rating maintained: UBS ($58→$54, Neutral) · Deutsche Bank ($54→$51, Hold) · Truist Financial ($69→$57, Buy) · Evercore ISI ($69→$57) · Williams Trading ($80→$57) · BTIG ($90→$75, Buy — Drbul noted margins “could inflect positively in Q2 FY2027”) · Telsey Advisory Group ($65→$55, Market Perform — Fernández noted EMEA “worse than expected”) · Barclays ($73→$67, Overweight maintained — China reset “likely to take four quarters to return to growth”) · Piper Sandler flagged flat EPS over nine months as “significantly below expectations.”

Bulls holding: BTIG (Buy, $75), Barclays (Overweight, $67), Truist (Buy, $57), Guggenheim (Buy, $74 — Siegel argued China was “better than feared” and EMEA was the real miss, while maintaining confidence management is “moving in the right direction”), DZ Bank (Buy), KeyBanc (Overweight, $75). The current sell-side distribution stands at approximately 19 Buy, 15 Hold, 1 Sell — a dramatic shift toward Hold from the Buy-heavy consensus that prevailed entering 2026. Needham’s Tom Nikic (Hold) characterised China as “a pressure point” with “unhealthy inventory levels” and noted the turnaround “could take longer than expected.” Average price target across the revised consensus: approximately $60–$67 — implying 35–50% upside from Friday’s close near $44, but with a 12–18 month recovery horizon that most investors are unwilling to underwrite in the current macro environment.

China — the structural problem that keeps getting worse

China is Nike’s most critical and most damaged market. Revenue contribution from Greater China has fallen from 18.6% of total sales in fiscal 2021 to 14.2% in fiscal 2025 — a five-percentage-point market share surrender driven by domestic brand competition from Anta Sports and Li-Ning, a broader consumer preference shift toward locally produced athletic goods, and the reputational consequences of Nike’s earlier supply chain controversies in the region. In Q3 FY2026, China revenue fell 10% — better than the 16% decline analysts had modelled, and a data point that bulls tried to frame as evidence of a floor. Management’s Q4 guidance of approximately –20% destroyed that narrative: the deterioration is not stabilising, it is accelerating into the seasonally important spring selling season. Needham’s characterisation of “unhealthy inventory levels” in China points to the underlying mechanism — Nike’s channel partners in China are sitting on excess inventory that requires discounting to clear, suppressing both revenue and gross margin simultaneously.

The competitive context makes China’s recovery structurally more difficult than it would be in any other market. Anta Sports and Li-Ning have both used the past three years of Nike’s strategic missteps — the over-rotation into Nike Direct that reduced wholesale channel investment, the supply chain controversy backlash, and the product pipeline gap — to establish deep roots in the Chinese consumer’s athletic footwear preference structure. Brand affinity built during a competitor’s period of domestic neglect is not easily reversed by product innovation alone; it requires sustained marketing, channel investment, and consumer experience improvement over multiple seasons. CEO Elliott Hill explicitly acknowledged on the call that China “is still in the early stages of a comeback” and that “the efforts are taking longer to fructify than he would like.” That combination — acknowledged structural competitive damage, early-stage recovery, and a now-disclosed 20% Q4 revenue decline — frames the China question not as a temporary cyclical trough but as a multi-year competitive repositioning challenge. Consumer sector investors tracking Nike’s China recovery have lost the timeline certainty that made the turnaround thesis investable.

EMEA, tariffs, and the Iran war’s freight cost overlay

China was not the only geographic pressure disclosed on Tuesday’s call. EMEA performance was characterised by Guggenheim’s Simeon Siegel as “worse than expected” — a notable disclosure given that EMEA had been one of the regions where recovery signal was strongest heading into Q3. BTIG’s Robert Drbul noted that Nike’s gross margin of 40.2% — down 130 basis points year-over-year — was driven specifically by “tariff costs in North America,” with the $1.5 billion annualised tariff headwind that management had previously disclosed flowing through exactly as expected. The Iran war has added a new cost pressure layer that did not exist when Q3’s tariff guidance was set: elevated freight and marine insurance costs on the trans-Pacific and Indian Ocean routes through which Nike moves production from its primary manufacturing base in Indonesia, Vietnam, and China. Nike may also face incremental pressure to deploy promotions to move inventory, particularly in China, which would further compress price realisation and gross margin in Q4.

The inventory picture compounds the margin concern. Inventory days of approximately 99 — well above the 70–80 day range that characterises a healthy Nike distribution cycle — signal ongoing channel clean-up that constrains the company’s ability to maximise full-price selling in any geography simultaneously. When inventory days are elevated, the path to gross margin recovery requires simultaneously reducing promotional activity (which restricts sell-through velocity) and improving channel mix toward full-price sales (which requires demand that currently does not exist in China). It is a circular problem with no clean resolution faster than the multi-quarter timeline that management has now explicitly guided.

The technical picture — RSI at 19.8 and what historical oversold signals mean for NKE

From a technical standpoint, NKE is in one of its most oversold conditions in the company’s public market history. An RSI of 19.82 places the stock in the bottom 2% of all historical readings for a name of Nike’s size and liquidity — a level that typically signals near-term exhaustion of the selling impulse rather than a fundamental buying signal. The ADX at 40.1 confirms that the downtrend is structurally strong rather than choppy and reversible, meaning that oversold conditions can persist for extended periods when the underlying trend driver (guidance deterioration, analyst downgrades) is generating consistent new selling pressure. Price is below the lower Bollinger Band at $46.42, a level that in normal volatility conditions would represent a statistical extreme. Nike’s 50-day SMA at approximately $58.43 and 200-day SMA at approximately $63.19 are now so far above the current price that any near-term rally would look like noise against those moving averages — a recovery to the 50-day would require a 32% gain from Friday’s close. That threshold is the technical marker most professional traders will watch for evidence that the primary downtrend has genuinely exhausted itself.

Historical precedent for 15%+ single-day drops in Nike is limited and instructive. The June 2024 equivalent — Nike’s prior worst single-day session — was followed by a period of consolidation before a modest recovery, but the stock never meaningfully reclaimed the pre-drop level before the next earnings cycle arrived with further disappointments. A contrarian position at current levels is supported by the RSI reading, the dividend yield of approximately 3.7%, Nike’s 24 consecutive years of dividend growth (approaching Dividend Aristocrat status at 25 years), and a forward P/E of approximately 17.5x — below its historical 20–30x range. But all of those quantitative supports require a turnaround catalyst to convert them into positive returns — and management has just pushed the catalyst date to Q3 FY2027 at the earliest. Understanding how earnings season data like this resets analyst models is essential context for positioning decisions around oversold situations.

What the bulls still see — Running, North America, and the World Cup option

Not every analyst capitulated. BTIG’s Robert Drbul — who cut his target from $90 to $75 but maintained his Buy rating — pointed to the most structurally important positive in Nike’s current operating picture: gross margins “could inflect positively in Q2 FY2027 as the company laps tariff pressures.” Drbul maintained that he sees “significant margin recovery opportunities in FY27 and into FY28.” Guggenheim’s Simeon Siegel kept his $74 target and Buy rating, arguing that Nike’s results showed “signs of moving in the right direction” and that management “sounded confident” in the recovery. Barclays maintained its Overweight with a $67 target, noting that while the Greater China reset will “likely take four quarters to return to growth,” the directional trajectory remains intact.

The objective positives in the Q3 report are real even if the market chose not to price them: Nike Running’s more than 20% quarterly growth rate is the clearest evidence that Hill’s product-first strategy is generating genuine traction where it matters most — the performance athletics category that is Nike’s founding DNA and most defensible competitive position. North America wholesale’s 3% growth confirms that the channel rebuild (returning to Amazon, rebuilding Foot Locker and Dick’s partnerships) is functioning. Nike Mind sold out and production was doubled. The FIFA 2026 World Cup — hosted across the U.S., Canada, and Mexico — is the largest single commercial catalyst in the company’s near-term pipeline, with a global marketing and product investment cycle that is already in execution. If consumer sentiment recovers from its current 53.3 historic-low reading as the Iran war resolves, Nike’s portfolio of performance and lifestyle brands is positioned to capture the discretionary rebound more directly than any competitor. The bull case is not dead — it is just nine months further away than anyone wanted to admit. For context on how to assess pre-market moves in NKE heading into Monday and the weeks ahead, PreMarket Daily’s education series provides relevant analytical framework.

The path to the June 25 earnings — what traders need to see before a re-rating

Nike’s next earnings report is scheduled for June 25, 2026. Between now and then, the market will be watching three specific data points to assess whether a re-rating is justified: first, China sell-through channel checks from analysts visiting retail markets in Beijing, Shanghai, and Chengdu — any evidence that inventory is clearing at stable or improving price realisation would materially change the thesis. Second, gross margin trajectory — if Q4 gross margin comes in at or above the 40.2% Q3 level despite the tariff and freight headwinds, it would signal that the pricing power floor has been found. Third, any constructive development in the Iran war that relieves freight and logistics cost pressure — a Strait of Hormuz reopening or a meaningful ceasefire would reduce one of the new cost variables that was not part of management’s original FY2026 guidance framework.

The dividend provides a specific income floor: Nike paid a $0.41 quarterly dividend on April 1, 2026 — its 24th consecutive year of dividend increases, placing it one year from Dividend Aristocrat status (25 consecutive years). At a stock price of approximately $44, the yield is approximately 3.7% — among the highest in Nike’s history as a public company and above the yield available on 2-year Treasuries at current rates. For income-oriented investors, that yield provides a tangible reason to hold while the turnaround develops. For growth investors who purchased Nike on the turnaround thesis, the June 25 earnings are the next binary event: either evidence of genuine China and EMEA stabilisation arrives, or the market re-prices the stock for a recovery timeline extending into fiscal 2028. NKE at $44 is pricing in the latter. The World Cup, Nike Running’s momentum, and management’s “Win Now” channel rebuild are pricing in the former. The gap between those two scenarios is where the next 20–30% of NKE’s price discovery will occur over the coming quarter.